Home > Insider Trading > Filing (0001209191-11-032903)

Filing Details

Accession Number:: 0001209191-11-032903
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-06-03 16:06:12
Reporting Period:: 2011-06-01

Filing Date:: 2011-06-03
Accepted Time:: 2011-06-03 16:06:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1180262	Herbalife Ltd.	HLF	Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1311173	Michael Johnson	800 W. Olympic Boulevard, #406 Los Angeles CA 90015	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-06-01	197,062	$8.80	880,046	No	4	M	Direct
Common Stock	Disposition	2011-06-01	108,761	$54.92	771,285	No	4	S	Direct
Common Stock	Disposition	2011-06-01	67,166	$55.89	704,119	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options (Right to Buy)	Disposition	2011-04-01	197,062	$0.00	197,062	$8.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
788,246		2013-04-03	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	110,000	Indirect	Beneficially owned through Spouse's GRAT
Common Stock	110,000	Indirect	Beneficially owned through GRAT
Common Stock	113,042	Indirect	Beneficially owned through Michael O. Johnson IRA

Footnotes

On May 17, 2011, the common stock of Herbalife Ltd. split 2-for-1, resulting in the reporting person's acquisition of 341,492 additional shares of common stock.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2010.
This transaction was executed in multiple trades at prices ranging from $54.51 to $55.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $55.51 to $56.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
On May 17, 2011, the common stock of Herbalife Ltd. split 2-for-1, resulting in the reporting person's acquisition of 55,000 additional shares of common stock.
On May 17, 2011, the common stock of Herbalife Ltd. split 2-for-1, resulting in the reporting person's acquisition of 56,521 additional shares of common stock.
These options were fully vested as of June 30, 2008.
On May 17, 2011, the common stock of Herbalife Ltd. split 2-for-1, resulting in the reporting person's acquisition of 492,654 nonqualifed stock options under this award as of that date.